Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$489,600.00
Apr 1, 2017
Copper Drug Complexes: Development of a novel class of drugs with significant potential for treatment of platinum insensitive cancers
$688,500.00
Apr 1, 2017
Exploring structure-function relationships between dietary fibre and the gut microbiome: Towards predicting and personalizing nutritional strategies.
$371,026.00
Apr 1, 2017
An innovative Trial Assessing Donor Sex on Recipient Mortality (iTADS)
$470,476.00
Apr 1, 2017
Distinct regulation of T cell fate and memory via differentially IL-2- and IL-7-activated mTORC1-KIF13A-M6PR axis and AMPK-FOXO-Eomes pathway
$832,320.00
Apr 1, 2017
Disease-Related Complications and Health Care Utilization in ADPKD
$359,549.00
Apr 1, 2017
Repeated Demyelination as an MRI Marker of Progressive Multiple Sclerosis
$684,675.00
Apr 1, 2017
Combined cancer therapy with NKT cell activation and oncolytic viruses
$918,000.00
Apr 1, 2017
Regulation of receptor mobility and spatial organization: Key factors in B cell activation
$835,570.00
Apr 1, 2017
Role of XAF1 and MAP kinase-activated protein kinase-2 in necrosome signaling
$1,074,825.00
Apr 1, 2017
Single-cell characterization of viral transcription- and translation-competent HIV and SIV reservoirs